The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality

Last updated: December 20, 2022
Sponsor: Maastricht University
Overall Status: Active - Recruiting

Phase

1/2

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05670184
NL80435.068.22
  • Ages 18-35
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this study is to assess the effects of LSD on neural synchrony, prosocial behavior, and relationship quality in healthy romantic couples.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Written Informed Consent
  • Understanding the procedures and the risks associated with the study.
  • Age between 18 and 35 years old.
  • Being in a steady relationship for at least 6 months.
  • Proficient knowledge of the English language
  • Previous experience with at least one psychedelic drug (psilocybin, LSD, mescaline,Ayahuasca, DMT, 5-MeO-DMT), but not within the past 3 months
  • Absence of any major medical condition as determined by medical examination andlaboratory analysis
  • Absence of any major psychological condition as determined by medical examination
  • Free from psychotropic medication
  • Participants must be willing to refrain from taking illicit psychoactive substancesduring the study.
  • Participants must be willing to drink only alcohol-free liquids and no coffee, blackor green tea, or energy drink after midnight of the evening before the study session,as well as during the study day.
  • Participants must be willing not to drive a traffic vehicle or to operate machineswithin 24 h after substance administration.
  • Normal weight, body mass index (weight/height2) between 18 and 28 kg/m2

Exclusion

Exclusion Criteria:

  • History of drug addiction (determined by the medical questionnaire, drug questionnaireand medical examination)
  • Previous experience of serious side effects to psychedelic drugs (anxiety or panicattacks)
  • Pregnancy or lactation
  • Hypertension (diastolic > 90 mmHg; systolic > 140 mmHg)
  • Current or history of psychiatric disorder (determined by the medical questionnaireand medical examination)
  • Psychotic disorder in first-degree relatives
  • Any chronic or acute medical condition
  • History of cardiac dysfunctions (arrhythmia, ischemic heart disease,…)
  • For women: no use of a reliable contraceptive
  • Tobacco smoking (>20 per day)
  • Excessive drinking (>20 alcoholic consumptions per week)
  • Experience with a full dose of a psychedelic within the last three months
  • Current use of SSRI medication

Study Design

Total Participants: 60
Study Start date:
January 01, 2023
Estimated Completion Date:
January 01, 2024

Study Description

Evidence is growing that psychedelic substances such as psilocybin, lysergic acid diethylamide (LSD) and ayahuasca could be a potential alternative treatment option for common and difficult to treat psychiatric conditions. One proposed mechanism that psychedelics target, which is a hallmark of seemingly all psychiatric disorders, are deficits in social cognitive abilities. However, the neural underpinnings of psychedelic induced alterations in prosocial behavior are currently unknown. The investigators hypothesize psychedelics increase such prosocial behaviors by increasing neural synchrony, which is the coupling of brain-to-brain activity across two or more people; it has been found to underlie social connection and various forms of shared prosocial behavior.

The current project will primarily assess whether LSD enhances neural synchrony between romantic partners. Second, the investigators will assess whether LSD enhances prosocial behavior between members of a dyad, thus replicating previous studies which assessed prosocial behavior within one individual at a time. The investigators will also assess the relationship between neural synchrony and outcome variables of the prosocial behaviour tasks. Lastly, it will be assessed whether LSD-induced changes in neural synchrony and/or prosocial behaviour affect persisting relationship quality. Oxytocin and cytokine concentrations, will also be quantified to investigate whether there is a relationship between these factors and changes in prosocial behaviour.

The study design will be conducted according to a double-blind, placebo-controlled, 2-way crossover design. Healthy participants (N=60) who are in a relationship (N=30 couples) will receive placebo and an oral dose of 50 µg of LSD. Between each condition, there will be a minimum of 14 days washout. This leads to a total study duration of minimally four weeks, for a participant to go through the medical examination and both drug conditions.

Connect with a study center

  • Maastricht University

    Maastricht,
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.